AbbVie

Industry group: Drugs

Headquarters: Illinois

Overview

Average pay of disclosed executives at AbbVie

Annual data

2018

On March 22, 2019, AbbVie reported executive compensation for fiscal year 2018.

NamePositionCompensationDetails
Richard A. GonzalezChairman of the Board and Chief Executive Officer$21,271,869
William J. ChaseExecutive Vice President, Finance and Administration$8,724,786
Robert A. MichaelSenior Vice President, Chief Financial Officer$3,118,888
Laura J. SchumacherVice Chairman, External Affairs and Chief Legal Officer$11,383,159
Carlos AlbanVice Chairman, Chief Commercial Officer$8,983,079
Michael E. SeverinoVice Chairman and President$8,607,359

Richard A. Gonzalez — Chairman of the Board and Chief Executive Officer — received the highest compensation: $21,271,869 in total.

In addition, Laura J. Schumacher — Vice Chairman, External Affairs and Chief Legal Officer — received a total compensation of $11,383,159; Carlos Alban received $8,983,079; William J. Chase received $8,724,786; Michael E. Severino received $8,607,359; Robert A. Michael received $3,118,888.

The company's median employee pay was $148,823.

2017

On March 19, 2018, AbbVie reported executive compensation for fiscal year 2017.

NamePositionCompensationDetails
Richard A. GonzalezChairman of the Board and Chief Executive Officer$22,625,243
William J. ChaseExecutive Vice President, Chief Financial Officer$12,044,593
Laura J. SchumacherExecutive Vice President, External Affairs, General Counsel and Corporate Secretary$14,979,356
Carlos AlbanExecutive Vice President, Global Commercial Operations$12,334,988
Michael E. SeverinoExecutive Vice President, Research & Development and Chief Scientific Officer$8,395,276

Richard A. Gonzalez — Chairman of the Board and Chief Executive Officer — received the highest compensation: $22,625,243 in total.

In addition, Laura J. Schumacher — Executive Vice President, External Affairs, General Counsel and Corporate Secretary — received a total compensation of $14,979,356; Carlos Alban received $12,334,988; William J. Chase received $12,044,593; Michael E. Severino received $8,395,276.

2016

NamePositionCompensationDetails
Richard A. GonzalezChairman of the Board and Chief Executive Officer$20,970,924
William J. ChaseExecutive Vice President, Chief Financial Officer$8,831,376
Laura J. SchumacherExecutive Vice President, External Affairs, General Counsel and Corporate Secretary$8,217,699
Carlos AlbanExecutive Vice President, Global Commercial Operations$8,216,918
Michael E. SeverinoExecutive Vice President, Research & Development and Chief Scientific Officer$7,243,863

Richard A. Gonzalez — Chairman of the Board and Chief Executive Officer — received the highest compensation: $20,970,924 in total.

In addition, William J. Chase — Executive Vice President, Chief Financial Officer — received a total compensation of $8,831,376; Laura J. Schumacher received $8,217,699; Carlos Alban received $8,216,918; Michael E. Severino received $7,243,863.

2015

On March 21, 2016, AbbVie reported executive compensation for fiscal year 2015.

NamePositionCompensationDetails
Richard A. GonzalezChairman of the Board and Chief Executive Officer$20,810,103
William J. ChaseExecutive Vice President, Chief Financial Officer$7,613,794
Laura J. SchumacherExecutive Vice President, External Affairs, General Counsel and Corporate Secretary$7,306,341
Carlos AlbanExecutive Vice President, Commercial Operations$7,049,639
Michael E. SeverinoExecutive Vice President, Research & Development and Chief Scientific Officer$6,603,805

Richard A. Gonzalez — Chairman of the Board and Chief Executive Officer — received the highest compensation: $20,810,103 in total.

In addition, William J. Chase — Executive Vice President, Chief Financial Officer — received a total compensation of $7,613,794; Laura J. Schumacher received $7,306,341; Carlos Alban received $7,049,639; Michael E. Severino received $6,603,805.

2014

NamePositionCompensationDetails
Richard A. GonzalezChairman of the Board and Chief Executive Officer$22,006,271
William J. ChaseExecutive Vice President, Chief Financial Officer$7,922,895
Laura J. SchumacherExecutive Vice President, External Affairs, General Counsel and Corporate Secretary$9,048,005
Carlos AlbanExecutive Vice President, Commercial Operations$9,262,861
Michael E. SeverinoExecutive Vice President, Research & Development and Chief Scientific Officer$11,542,746

Richard A. Gonzalez — Chairman of the Board and Chief Executive Officer — received the highest compensation: $22,006,271 in total.

In addition, Michael E. Severino — Executive Vice President, Research & Development and Chief Scientific Officer — received a total compensation of $11,542,746; Carlos Alban received $9,262,861; Laura J. Schumacher received $9,048,005; William J. Chase received $7,922,895.

2013

NamePositionCompensationDetails
Richard A. GonzalezChairman of the Board and Chief Executive Officer$18,176,794
William J. ChaseExecutive Vice President, Chief Financial Officer$5,112,723
Laura J. SchumacherExecutive Vice President, External Affairs, General Counsel and Corporate Secretary$6,996,298
Carlos AlbanExecutive Vice President, Commercial Operations$5,135,169
Timothy J. RichmondSenior Vice President, Human Resources$3,302,519

Richard A. Gonzalez — Chairman of the Board and Chief Executive Officer — received the highest compensation: $18,176,794 in total.

In addition, Laura J. Schumacher — Executive Vice President, External Affairs, General Counsel and Corporate Secretary — received a total compensation of $6,996,298; Carlos Alban received $5,135,169; William J. Chase received $5,112,723; Timothy J. Richmond received $3,302,519.

2012

NamePositionCompensationDetails
Richard A. GonzalezChairman of the Board and Chief Executive Officer$7,949,217
Carlos AlbanExecutive Vice President, Commercial Operations$6,529,670
Laura J. SchumacherExecutive Vice President, Business Development, External Affairs and General Counsel$10,192,748
William J. ChaseExecutive Vice President, Chief Financial Officer$4,218,917
John M. LeonardSenior Vice President, Pharmaceuticals, Research and Development$5,478,115

Laura J. Schumacher — Executive Vice President, Business Development, External Affairs and General Counsel — received the highest compensation: $10,192,748 in total.

In addition, Richard A. Gonzalez — Chairman of the Board and Chief Executive Officer — received a total compensation of $7,949,217; Carlos Alban received $6,529,670; John M. Leonard received $5,478,115; William J. Chase received $4,218,917.

2011

NamePositionCompensationDetails
John M. LeonardSenior Vice President, Pharmaceuticals, Research and Development$3,497,811
Richard A. GonzalezChairman of the Board and Chief Executive Officer$5,552,839
Laura J. SchumacherExecutive Vice President, Business Development, External Affairs and General Counsel$5,567,493
William J. ChaseExecutive Vice President, Chief Financial Officer$1,819,491
Carlos AlbanExecutive Vice President, Commercial Operations$3,892,335

Laura J. Schumacher — Executive Vice President, Business Development, External Affairs and General Counsel — received the highest compensation: $5,567,493 in total.

In addition, Richard A. Gonzalez — Chairman of the Board and Chief Executive Officer — received a total compensation of $5,552,839; Carlos Alban received $3,892,335; John M. Leonard received $3,497,811; William J. Chase received $1,819,491.

2010

NamePositionCompensationDetails
Richard A. GonzalezExecutive Vice President, Pharmaceutical Products Group$7,600,509
Laura J. SchumacherExecutive Vice President, General Counsel, and Corporate Secretary$7,127,201

Richard A. Gonzalez — Executive Vice President, Pharmaceutical Products Group — received the highest compensation: $7,600,509 in total.

In addition, Laura J. Schumacher — Executive Vice President, General Counsel, and Corporate Secretary — received a total compensation of $7,127,201.